We would like to place cookies on your computer to help us make this website better. To find out more about the cookies, see our privacy notice.

EUBREAST Network – Trials & Projects

Trials & Projects

 

EUBREAST 01 (R) 

EUBREAST 02 (R) COVID survey

EUBREAST 03 (R) AXSANA

EUBREAST 04 (R) MELODY

EUBREAST 05 (R) SERMA

EUBREAST 06 (R) OMA (in cooperation with OPBC)

EUBREAST 07 (E) Webinar series 2021

EUBREAST 08 (R) PST Survey 

EUBREAST 09 (E) OPBC / Toolbox / EUBREAST consensus conference 1 on lymph node management

EUBREAST 10 (E) OPBC / Toolbox / EUBREAST consensus conference 2 on lymph node management

EUBREAST 11 (R) I-PREPARE

EUBREAST 12 (E) EUBREAST Educational Program

EUBREAST 13 (R) UEMS - EUBREAST Breast Care Survey

EUBREAST 14 (R) OPBC05 - EUBREAST 14 ICARO Study

EUBREAST 15 (R) GraMaReg

 

 

Trials supported by EUBREAST

Additional projects EUBREAST has help promote

 

 

EUBREAST 01 (R): Omission of sentinel lymph node biopsy in triple-negative and HER2-positive breast cancer patients with radiologic and pathologic complete response in the breast after neoadjuvant systemic therapy: a single-arm, prospective surgical trial.

 

EUBREAST 02 (R) International Survey on breast cancer management in the Covid 19 era

Topic: Changes in breast cancer management during the Corona Virus Disease 19 pandemic

PI:  Maria Luisa Gasparri

Core team: ML Gasparri, OD Gentilini, D Lueftner, T Kuehn, O Kaidar-Person, P Poortmans

Supporting societies:  

Study design: international web-survey

Brief presentation: Breast cancer management was considerably modified during the COVID-19 pandemic. This was the first, fastest, and largest survey among breast specialists investigating this topic and showing a snapshot on the international discrepancies.  In ten days, 377 breast units from 41 countries adhered and responded our questionnaire.

Full publication available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256546/pdf/main.pdf

 

EUBREAST 03 (R) AXSANA

 

EUBREAST 04 (R) MELODY

 

EUBREAST 05 (R) SERMA (Seroma of the Mammary gland)

 

EUBREAST 06 (R) OMA (in cooperation with OPBC)

 

EUBREAST 07 (E) Webinar Series 

EUBREAST 08 (R) International Survey on lymph node management in node positive breast cancer patients after neoadjuvant chemotherapy

Topic:International discrepancies on the axillary management amongradiation oncologists and breast surgeons

PI:  Maria Luisa Gasparri

Core team: M.L. Gasparri, J. de Boniface, P. Poortmans, T. Kühn, O.D. Gentilini, O. Kaidar-Person

Supporting societies

Study design: international web-survey

Brief presentation: There is no consensus on the axillary management following primary systemic treatment in clinically node-positive breast cancer patients. The discrepancies in the breast surgical  and radiation therapy approaches have been «quantified» testing a representative sample of 349 breast surgeons and radiation oncologists from 45 countries. The resulted heterogeneity among countries and centres, reinforces the rationale of the ongoing AXSANA (EUBREAST-3) study.

Full publication:  Not yet available

EUBREAST 09 (E) OPBC / Toolbox / EUBREAST consensus conference 1 on lymph node management

Upcoming event: September 1st 2022, 13:00 - 17:00 CET

2022 virtual OPBC consensus conference on uncertainties and controviersies in axillary management of patients with breast cancer

 

Protocol on first phase of the OPBC 2022 / EUBREAST / Toolbox2 Project (pdf)
Protocol on first phase of the OPBC 2022 / EUBREAST / Toolbox2 Project (docx)

 

EUBREAST 10 (E) OPBC / Toolbox / EUBREAST consensus conference 2 on lymph node management

EUBREAST 11 (R) I-PREPARE 

EUBREAST 12 (E) EUBREAST EDUCATIONAL PROGRAM 

EUBREAST 13 (R) UEMS - EUBREAST Breast Care Survey

Topic: Breast Care Specialists Training

Core Team: Prof. Florentia Peintinger, Prof. Thorsten Kuehn, Dr. Med. dr. Phil. Maria Luisa Gasparri, Dr. Angelika Rief

Study Design: International, multidisplicinary online survey

Brief Presentation: The European Union of Medical Specialists (UEMS-Multidisciplinary Joint Committee Breast Care) and the European Breast Cancer Research Association of Surgical Trialists (EUBREAST) aim to evaluate the training of breast care specialists across Europe and abroad. This survey should provide an incentive for international harmonization and quality improvement.

Click here: Link to Breast Care Survey

 

EUBREAST 14 (R) OPBC05 - EUBREAST 14 ICARO Study

EUBREAST 15 (R) GraMaReg (GRAnulomatous MAstitis REGistry Study)

Trials supported by EUBREAST

Completed Trials

AGO 35 

 

TATTOO-Study: Tattooing suspicious axillary lymph nodes in breast cancer patients treated by primary systemic therapy 

 

SOUND: Sentinel node vs Observation after axillary Ultra-souND

 

INSEMA


 

NEONOD 2

 

SENOMAC


 

Ongoing Trials

TAXIS


Additional projects EUBREAST has promoted

Breast cancer treatment in the COVID 19 pandemic EUBREAST offers access to relevant literature and recommendations for physicians and patients.

 

EUBREAST would like to share the message of the European Cancer Organisation’s Time to Act campaign -
Don’t let Covid-19 stop you from tackling Cancer  https://www.europeancancer.org/timetoact

 

EUBREAST supports the PER.D.I.T.A survey from i BRA-NET, please share this link with colleagues and friends
Link to the study